Skip to content

To Compare Effect of Pippalyadi Gutika Anjanam and Antioxidant Therapy in Kapahaj kaach- Senile Immature Cataract

A Comparative Assessment of Effect of Pippalyadi Gutika Anjanam and Antioxidant Therapy in Kaphaj Kaach (Senile Immature Cataract).

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049927
Enrollment
84
Registered
2023-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H258- Other age-related cataract

Interventions

None listed

Sponsors

Dr Vaishnavi Shashikant Chaudhari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with Senile Immature Cortical Cataract. 2.Visual Acuity Between 6/9-6/36 by Snellenâ??s Chart.

Exclusion criteria

Exclusion criteria: 1. Patients with Nuclear cataract, Mature cataract and hyper mature cataract. 2. Visual acuity - Less than 6/36 by Snellenâ??s Chart. 3. Patients With Congenital and Developmental, Traumatic, Complicated or Metabolic Cataract and Posterior Segment Disorders. 4. Any other Ocular Pathology that can cause Diminution of Vision. 5. Patients on Any Steroidal Therapy. 6. Patients with Systemic Diseases Like Uncontrolled Diabetes Mellitus, Uncontrolled Hypertension etc.

Design outcomes

Primary

MeasureTime frame
Maintain Visual AcuityTimepoint: Follow Up on 30th day, 60th day, 90th day, 120th day

Secondary

MeasureTime frame
To Stop Further Growth of Cortical Immature Senile CataractTimepoint: Follow up on 30th day, 60th day,90th day, 120th day

Countries

India

Contacts

Public ContactDr Sunita Magar

G.D. Pol foundations Y.M.T. Ayurvedic Medical College and PG Institute Kharghar

sunitamagar66@gmail.com9987335024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026